Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.

Expert review of anti-infective therapy - 1 Jun 2011

Katz Jacqueline M, Hancock Kathy, Xu Xiyan

Abstract excerpt

Serological techniques play a critical role in various aspects of influenza surveillance, vaccine development and evaluation, and sometimes in diagnosis, particularly for novel influenza virus infections of humans. Because individuals are repeatedly exposed to antigenically and genetically diverse influenza viruses over a lifetime, the gold standard for detection of a recent influenza virus infection or response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artifacts
Share to Cross Reactions
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemagglutination Inhibition Tests

Share to Hemagglutinins

Share to Influenza Vaccines

Share to Orthomyxoviridae

Share to Vaccines, Inactivated

Source

Identifiers

PMID: 21692672
DOI: 10.1586/eri.11.51

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.PMID 21692672Read ↗

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-Like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza VaccineSemantic proximity Read ↗

Development and optimisation of Influenza C and Influenza D pseudotyped virusesSemantic proximity Read ↗

A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy AdultsSemantic proximity Read ↗

Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin MutationsSemantic proximity Read ↗

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in HumansSemantic proximity Read ↗

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)Semantic proximity Read ↗

Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2Semantic proximity Read ↗

A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigensSemantic proximity Read ↗

Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humansSemantic proximity Read ↗

Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase SubtypeSemantic proximity Read ↗

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved EffectivenessSemantic proximity Read ↗

Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018–May 2019Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.